The study on the global Market size for Autoimmune Disease Diagnostics evaluated the historical and current performance of this Market size, especially highlighting the key trends and growth opportunities.
— Autoimmune Disease Diagnostics Market report provides major statistics on the state of the industry and is a valuable source of opportunities and developments for firms and individuals attentive in the market. This report majorly focused on the Autoimmune Disease Diagnostics market growth in demand, investment, trade and productivity with company profiles, product picture and specification. Autoimmune Disease Diagnostics market report forecasts revenues for key applications across key regions with Manufacturing Cost Structure Analysis, Product Overview and Scope of Autoimmune Disease Diagnostics market.
The systemic autoimmune disease diagnostics is projected to grow at a robust CAGR of 3.9% over the forecast timeframe. Technological advancements such as development of multiple autoantibodies screening tests enable early disease diagnosis and treatment stimulating market growth.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467753/?utm_source=MM&utm_medium=VS
Autoimmune Disease Diagnostics Market will exceed USD 16.0 billion by 2025; as per a new research report.
With more than 50 million people suffering from autoimmune diseases in the U.S. alone, there is a stronger need to focus on the strategies to cater to such diseases and the cost burden associated with it. Presence of favorable government initiatives to facilitate healthcare spending pertaining to autoimmune disorders is one of the major profit-rendering drivers for the global market growth over the forecast period.
Increase in prevalence of systemic and localized autoimmune diseases should drive global autoimmune disease diagnostics market during the forecast period. Based on American Autoimmune Related Diseases Association (AARDA) more than 50 million Americans are affected by autoimmune disorders and the number is expected to increase at an alarming rate over the coming few years. Furthermore, these diseases are predominantly occurring in women and the prevalence is 75% more than the men as per AARDA leading to become one of the top ten causes of mortality in women across all age groups.
Localized autoimmune disease diagnostics market accounted for more than 66.0% revenue share in 2018. Increasing demand for diagnostics kits and assays owing to the high prevalence of autoimmune disorders such as Hashimoto’s thyroiditis, type 1 diabetes and pernicious anemia are factors propelling business growth. Rising patient awareness levels due to government efforts is yet another factor contributing to segmental revenue growth over the forecast period.
U.S. dominated the North America autoimmune disease diagnostics market and was valued at around USD 5,003.0 million in the year 2018. Presence of sophisticated healthcare facilities, high awareness pertaining to benefits of the early and accurate diagnosis, and higher healthcare expenditure levels in the country will accelerate the U.S. autoimmune disease diagnostics market during the forecast period. Asia Pacific will grow swiftly during the forecast period owing to rapidly increasing patient pool, greater awareness pertaining to autoimmune diseases, and growing healthcare industry in emerging Asian economies.
The major industry players in the autoimmune disease diagnostics market are Abbott Laboratories, Siemens AG, Beckman Coulter Inc., Quest Diagnostics, SQI Diagnostics, Bio-Rad Laboratories, Inc, EUROIMMUN, AESKU Diagnostics, Inova diagnostics Inc. and bioMerieux SA. These key industry players focus on certain strategic decisions that help them to sustain tough competition in the market. Companies focus on improvising and adding value to the product portfolio that enhance the performance and hence will increase the demand of products.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467753/?utm_source=MM&utm_medium=VS
Chapter 1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
22.214.171.124. Paid sources
126.96.36.199. Unpaid sources
Chapter 2. Executive Summary
2.1. Autoimmune disease diagnostics industry 360 degree synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Regional trends
Chapter 3. Autoimmune Disease Diagnostics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers
188.8.131.52. High prevalence of autoimmune diseases worldwide
184.108.40.206. Rising investments for research in North America
220.127.116.11. Encouraging government support in developed countries for research
18.104.22.168. Initiatives by public and private organizations to increase patient awareness
22.214.171.124. Increasing adoption of lab automation technology in U.S. and Europe
3.3.2. Industry pitfalls & challenges
126.96.36.199. Long waiting time for diagnostic tests results
188.8.131.52. Inadequacy of skilled healthcare professionals in developing countries
3.4. Growth potential analysis
3.4.1. By product
3.5. Porter's analysis
3.6. Competitive landscape, 2017
3.6.1. Strategy dashboard
3.7. PESTEL analysis
Chapter 4. Autoimmune Disease Diagnostics Market, By Product
4.1. Key segment trends
4.2. Systemic autoimmune disease diagnostics
4.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.2. Rheumatoid arthritis diagnostics
184.108.40.206. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.3. Ankylosing spondylitis diagnostics
220.127.116.11. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.4. Systemic lupus erythematosus diagnostics
18.104.22.168. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
22.214.171.124. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.3. Localized autoimmune disease diagnostics
4.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size, Status and Forecast 2019-2025
In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases.
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Release ID: 524617